[144] Alignment Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) disclosed a proposed sale of 18,600 common shares under Rule 144, with an aggregate market value of $272,304.00. The shares were originally acquired 03/26/2021 as pre-IPO issuances exchanged for partnership units. The filing names Morgan Stanley Smith Barney LLC as the broker and lists an approximate sale date of 08/13/2025. The notice also records a related 10b5-1 sale executed on 08/11/2025 generating $270,425.40 in gross proceeds. The filer affirms they are not aware of undisclosed material adverse information about the issuer.

Positive

• Sale executed under a 10b5-1 plan, which can reduce insider trading concerns by indicating pre-planned disposition
• Transaction size is immaterial: 18,600 shares versus 198,031,417 shares outstanding (~0.0094%), limiting potential market impact

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider sale is immaterial relative to outstanding shares and executed under a 10b5-1 framework, suggesting routine disposition.

The filing reports a proposed Rule 144 sale of 18,600 common shares valued at $272,304.00 against 198,031,417 shares outstanding, representing approximately 0.0094% of the share base. The shares were acquired pre-IPO on 03/26/2021. A contemporaneous 10b5-1 sale on 08/11/2025 produced $270,425.40, indicating at least some sales were executed under an automated plan. For investors, the size and structured nature of the transactions point to limited market impact rather than a material change in ownership or control.

Corporate Governance Expert

TL;DR: Use of 10b5-1 and a small sale size suggest governance-compliant insider selling with low informational impact.

The notice explicitly references a 10b5-1 sale and includes the required Rule 144 representations. The securities were originally issued pre-IPO in exchange for partnership units, which is disclosed in the acquisition section. Given the disclosure and the very small fraction of outstanding shares involved, these transactions appear procedural and compliant, reducing the likelihood of governance concerns or signaling of undisclosed company issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18600	272304.00	198031417	08/13/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/26/2021	Shares Issued Pre-IPO in exchange for Partnership Units	Issuer			18600	03/26/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for HYONG J KIM 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	08/11/2025	18600	270425.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares did ALHC disclose for sale in the Form 144?

The filing covers 18,600 common shares proposed for sale under Rule 144.

How much are the 18,600 ALHC shares valued at in the filing?

The aggregate market value is stated as $272,304.00.

When were the shares being sold originally acquired?

The shares were acquired on 03/26/2021 as pre-IPO shares issued in exchange for partnership units.

Was a broker involved in the proposed ALHC sale?

Yes, the filing names Morgan Stanley Smith Barney LLC as the broker handling the sale.

Did the filer report any sales in the past three months?

Yes, the filing records a 10b5-1 sale on 08/11/2025 of 18,600 shares generating $270,425.40 in gross proceeds.